
|
Robert F. Riley, MD, MS, FSCAI Moderator Background, Impetus, and Scope of the Document
|
 |
Jim Januzzi, MD Biomarkers, Biomarkers, and More Biomarkers? |

|
Andrew Choi, MD Pros and Cons of Diagnostic Modalities Used to Evaluate Chest Pain |
 |
Mirvat Alasnag, MD, FSCAI Incorporating Gender, Age, Ethnicity, and Cultural Norms into Chest Pain Evaluations |

|
Michael J. Gallagher, MD Evaluating Acute Chest Pain |
 |
Saurav Chatterjee, MD How to Evaluate Stable and Chronic Chest Pain |

|
Hani Jneid, MD, FSCAI Evaluating Special Populations |
 |
Farouc Jaffer, MD, PhD, FSCAI Co-Moderator The Role of Coronary Angiography in 2022
|

|
Jennifer Tremmel, MD, MS, FSCAI INOCA as a Cause of Chest Pain |

|
Jacqueline Tamis-Holland, MD, FSCAI Evaluating Non-Obstructive ACS Causes of Acute Chest Pain Syndromes
|

|
Debabrata Mukherjee, MD, FSCAI Top Ten Take Home Messages |

|
Timothy Henry, MD, MSCAI Future Directions
|
 |
James Goldstein, MD, FSCAI Co-Moderator |
|
|